Editorial
doi: 10.1080/14737175.2020.1862651.
Epub 2021 Jan 11.
Novel therapeutic options for Dravet and Lennox-Gastaut syndrome
Affiliations
- PMID: 33297778
- DOI: 10.1080/14737175.2020.1862651
Item in Clipboard
Editorial
Novel therapeutic options for Dravet and Lennox-Gastaut syndrome
Expert Rev Neurother.
2021 Nov.
No abstract available
Keywords: Cannabidiol; Dravet syndrome; Lennox-Gastaut syndrome; antiseizure medications; epilepsy; fenfluramine.
Similar articles
-
Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.Drugs Today (Barc). 2019 Mar;55(3):177-196. doi: 10.1358/dot.2019.55.3.2909248. Drugs Today (Barc). 2019. PMID: 30938373 Review.
-
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome.Expert Rev Neurother. 2021 Jan;21(1):99-110. doi: 10.1080/14737175.2021.1834383. Epub 2020 Oct 25. Expert Rev Neurother. 2021. PMID: 33026899 Review.
-
The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results.Epilepsia. 2021 Apr;62(4):857-873. doi: 10.1111/epi.16849. Epub 2021 Feb 27. Epilepsia. 2021. PMID: 33638459 Review.
-
Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.Epilepsy Res. 2019 Aug;154:13-20. doi: 10.1016/j.eplepsyres.2019.03.015. Epub 2019 Mar 25. Epilepsy Res. 2019. PMID: 31022635 Clinical Trial.
-
Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.Rev Neurol. 2021 Sep 10;73(S01):S1-S8. doi: 10.33588/rn.73S01.2021250. Rev Neurol. 2021. PMID: 34486101 Review. English, Spanish.
Cited by
-
Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding.Neuropsychiatr Dis Treat. 2023 Sep 26;19:2013-2025. doi: 10.2147/NDT.S417676. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 37790801 Free PMC article. Review.
-
Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine.Front Pharmacol. 2022 May 20;13:832929. doi: 10.3389/fphar.2022.832929. eCollection 2022. Front Pharmacol. 2022. PMID: 35668937 Free PMC article. Review.
-
The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies.Front Neurol. 2021 Jun 22;12:674483. doi: 10.3389/fneur.2021.674483. eCollection 2021. Front Neurol. 2021. PMID: 34239494 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
